H.I.G. Capital Builds Comprehensive Healthcare Services Platform Through Specialized Provider Acquisitions

Healthcare services diversification has accelerated across H.I.G. Capital’s investment portfolio, with the firm assembling specialized providers spanning revenue cycle management, pharmaceutical compounding, infusion therapy, and occupational health services. The strategy positions H.I.G. to benefit from healthcare industry trends including value-based care adoption, regulatory complexity, and specialized treatment demand.

GetixHealth’s acquisition adds revenue cycle management capabilities serving major health systems nationwide. Founded in 1992 and headquartered in Sugar Land, Texas, the company provides comprehensive services including patient responsibility management, eligibility verification, claims resolution, and insurance billing that address the complex reimbursement environment facing healthcare providers.

“Over the last decade, we have made investments in our team, solutions, and proprietary technologies to position GetixHealth as a leading partner to healthcare providers,” said Kevin Lonergan, Chief Executive Officer. “Due to the complex reimbursement environment and evolving regulatory landscape, our customers are increasingly turning to us to address their revenue cycle challenges.”

Anthony Chambers, Managing Director at H.I.G., emphasized the company’s market position: “GetixHealth is a vital partner to healthcare providers, including many of the nation’s largest health systems. We are impressed by the Company’s capabilities and stellar reputation among its clients and patients.”

Specialized Infusion Services and Pharmacy Operations

Soleo Health’s sale to Court Square Capital and WindRose Health Investors demonstrates H.I.G.’s success in developing specialty healthcare platforms. The Frisco, Texas-based company operates 26 pharmacies and more than 30 ambulatory infusion suites across the United States, serving patients with complex, rare, and ultra-rare medical conditions.

“H.I.G. has been an exceptional partner to Soleo and instrumental in helping us build the Company into the market leader we are today,” said Drew Walk, President and Chief Executive Officer. “H.I.G. supported several investments in talent and infrastructure, strengthening our ability to reach more patients and provide exceptional care across our network.”

During H.I.G.’s ownership, Soleo expanded its footprint through de novo pharmacy and infusion suite development while introducing a differentiated therapy-specific clinical model. The company diversified payor relationships, site-of-care options, and therapy offerings while making key executive hires that strengthened operational capabilities.

Scott Zhu, Managing Director at H.I.G., noted the transformation: “Drew and the Soleo management team have done an outstanding job transforming Soleo from a regional infusion player into a national specialty care provider, with a variety of compelling growth opportunities.”

Pharmaceutical Compounding and Specialty Services

ITH Group’s UK operations provide aseptic pharmaceutical compounding services addressing supply shortages and specialized medication needs. The London-based company prepares bespoke injectable medications for patients requiring customized formulations unavailable through traditional pharmaceutical channels.

“Since our founding in 2008, ITH has consistently grown by investing in our people and enhancing the services we provide to patients,” said Adam Bloom, CEO. “Today, we are proud to be a leading provider of compounding services in the UK, supporting both the NHS and private healthcare sectors.”

ITH holds market-leading positions in chemotherapy, total parenteral nutrition, and central intravenous additive services. The company’s facilities operate under stringent quality standards serving both adult and neonatal patient populations requiring specialized medications.

John Harper, Managing Director at H.I.G., outlined growth opportunities: “The Company’s track record of reliably providing compounded pharmaceuticals to NHS and private customers in an inherently undersupplied market, combined with H.I.G.’s history of supporting capacity expansion in its portfolio companies, underpins an exciting next chapter for ITH.”

Occupational Health Services Platform

Avanta Salud Integral’s acquisition establishes H.I.G.’s presence in European occupational health services. The Valencia-based company serves more than 100,000 clients covering over one million employees through a network exceeding 250 medical centers and mobile units across Spain.

“We are incredibly proud of what we have built at Avanta, a family of almost 2,500 outstanding professionals, trusted by thousands of businesses to keep their employees safe, healthy, and supported,” said Josep Pla, President and Founder. “Our commitment to delivering the highest-quality services has been key to bringing us to where we are today.”

Avanta provides both mandatory occupational health services required by Spanish and EU law, as well as elective employee health programs addressing mental health support, absenteeism management, and preventive care. These offerings help employers reduce lost productivity and enhance workforce well-being.

Rohin Jain, Managing Director at H.I.G. Middle Market Europe, emphasized the investment rationale: “Josep and his team have built a best-in-class platform in Avanta — combining scale, quality, and exceptional integration capabilities in a highly resilient and regulated sector.”

H.I.G. Capital’s Healthcare Investment Approach

The firm’s healthcare strategy targets specialized service providers with recurring revenue models, regulatory advantages, and growth potential through market expansion or service line development. H.I.G. seeks companies addressing critical healthcare needs with limited alternative solutions.

Revenue cycle management services benefit from increasing healthcare reimbursement complexity and provider focus on financial performance optimization. GetixHealth’s technology-enabled solutions and three decades of experience position the company to capture growing demand for outsourced revenue cycle services.

Specialty pharmacy and infusion services address complex medication needs requiring specialized handling, administration, and patient support. These services command premium reimbursement while creating strong relationships with patients and referring providers that support high retention rates.

Pharmaceutical compounding fills critical supply gaps in healthcare systems while addressing unique patient requirements unavailable through mass-produced medications. ITH’s technical capabilities and quality certifications create barriers to entry that protect market position and support premium pricing.

Market Dynamics and Growth Opportunities

Healthcare services consolidation continues as providers seek specialized capabilities, scale efficiencies, and geographic expansion opportunities. H.I.G.’s platform development approach creates value through acquisitions that enhance service offerings and extend market coverage.

Aging demographics drive demand for specialty healthcare services including infusion therapy, complex medication management, and chronic disease treatment. Healthcare providers increasingly rely on specialized partners with expertise in rare disease management and complex care coordination.

Value-based care models incentivize healthcare providers to optimize outcomes while controlling costs, creating demand for services that improve patient adherence, reduce complications, and enhance care quality. Specialty pharmacy and infusion providers address these objectives through comprehensive patient support programs.

Regulatory complexity in healthcare reimbursement, quality reporting, and compliance creates opportunities for specialized service providers with expertise navigating these requirements. Revenue cycle management companies benefit from provider outsourcing decisions driven by regulatory burden and financial pressures.

Operational Excellence and Quality Standards

H.I.G.’s healthcare portfolio companies emphasize quality standards, regulatory compliance, and patient safety as foundational elements of operations. The firm works with management teams to implement best practices, maintain certifications, and measure performance metrics.

Soleo Health maintains accreditation from URAC, ACHC with Distinction in Rare Diseases and Orphan Drugs, the National Association of Boards of Pharmacy, and the Joint Commission. These certifications demonstrate quality standards and enable participation in preferred provider networks.

ITH Group’s aseptic compounding facilities operate under stringent quality protocols ensuring medication safety and efficacy. The company’s technical expertise and quality systems enable reliable service delivery to healthcare providers requiring specialized pharmaceutical preparations.

GetixHealth’s revenue cycle technology platforms incorporate data security, HIPAA compliance, and integration capabilities that address healthcare provider requirements. The company’s three decades of experience inform process design and technology development that optimize financial performance.

Investment Outlook and Strategic Priorities

H.I.G.’s healthcare investments continue emphasizing specialized service providers with defensible market positions and growth opportunities through operational improvements or market expansion. The firm’s sector expertise and operational resources provide competitive advantages in identifying and developing healthcare service businesses.

Specialty pharmacy services, diagnostic testing, physician practice management, and healthcare technology represent potential areas for future investments. H.I.G. seeks companies with proven business models, experienced management teams, and scalable operations addressing critical healthcare needs.

Current healthcare portfolio companies benefit from H.I.G.’s network, sector knowledge, and capital resources while maintaining operational independence and provider relationships. The firm’s track record includes successful investments across healthcare subsectors and market conditions demonstrating adaptability and sector expertise that support consistent value creation.